CYPH — Cypherpunk Technologies Share News
0.000.00%
Last trade - 00:00- $321.14m
- $313.51m
Brief: Leap Therapeutics Q1 Net Income USD -15.435 Million
Brief: Leap Therapeutics - Announces 50% Workforce Reduction In Strategic Restructuring - SEC Filing
Leap Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview
Leap Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Leap Therapeutics Reports Positive Updated Data from Sirexatamab Colorectal Cancer Study
Brief: Leap Therapeutics Reports Fourth Quarter And FY 2024 Results
Leap Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview
Leap Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-F5, Nextracker, Stryker
U.S. STOCKS ON THE MOVE-Sharps Technology, Smithfield Foods, Coca-Cola
U.S. STOCKS ON THE MOVE-Cameco, BlackSky, Silexion Therapeutics
U.S. STOCKS ON THE MOVE-Royal Caribbean, RTX, Autodesk
Leap tumbles on discontinuation of gastric cancer treatment trials
Advisory: Alert on fund raise wrongly tagged to Leap Therapeutics withdrawn
Leap Therapeutics Inc reports results for the quarter - Earnings Summary
Leap Therapeutics Inc expected to post a loss of 48 cents a share - Earnings Preview
Leap Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Leap Therapeutics Inc expected to post a loss of 43 cents a share - Earnings Preview
Leap Therapeutics Inc reports results for the quarter ended in March - Earnings Summary